Igor Artemiev, head of FAS (Federal Antimonopoly Service) gave a
briefing on "Current practice and further plans of FAS "
which took place on March 6, 2017 in the office of Association of
European Business (AEB). The briefing was attended by the
association members and representatives of mass media.
In the course of this meeting, the parties discussed a broad
spectrum of topics related to antitrust regulation in various
spheres of national economy. The major part of this event was
dedicated to the issues of antitrust regulations in the field of
pharmaceuticals and state procurement of medicines.
Specifically, Igor Artemiev stated that FAS frowns upon a
so-called "odd man out" rule applied in state procurement
of medicinal drugs and products. According to this rule, if there
are at least two or more offers for supplying medicinal drugs
produced in the Eurasian Economic Union in the tender procedure,
the foreign suppliers are not allowed to participate. According